Evaluation of CYFRA 21.1 as a Dedifferentiation Marker of Advanced Thyroid Cancer.
131I refractory
18F-Fluorodeoxyglucose positron emission tomography-computed tomography
dedifferentiation
thyroid cancer
Journal
Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India
ISSN: 0972-3919
Titre abrégé: Indian J Nucl Med
Pays: India
ID NLM: 8901274
Informations de publication
Date de publication:
Historique:
received:
14
08
2019
revised:
20
09
2019
accepted:
01
10
2019
entrez:
1
5
2020
pubmed:
1
5
2020
medline:
1
5
2020
Statut:
ppublish
Résumé
Well-differentiated thyroid carcinomas have good prognosis, but as it de-differentiates, the survival rates go down. Early identification of such patients needs a marker which indicates the dedifferentiation process. CYFRA 21.1 has also shown to be increased in patients with Well-differentiated thyroid cancer patients with known distant metastases were accrued and tested for stimulated and unstimulated thyroglobulin and CYFRA 21.1. All patients underwent CYFRA 21.1 levels were significantly elevated in CYFRA 21.1 can be utilized to differentiate between
Identifiants
pubmed: 32351265
doi: 10.4103/ijnm.IJNM_148_19
pii: IJNM-35-116
pmc: PMC7182327
doi:
Types de publication
Journal Article
Langues
eng
Pagination
116-121Informations de copyright
Copyright: © 2020 Indian Journal of Nuclear Medicine.
Déclaration de conflit d'intérêts
There are no conflicts of interest.
Références
Int J Oncol. 2002 Aug;21(2):441-5
pubmed: 12118343
Eur J Endocrinol. 2012 Dec;167(6):793-7
pubmed: 22989467
Lancet Oncol. 2007 Feb;8(2):148-56
pubmed: 17267329
Pathologe. 1996 Nov;17(6):425-32
pubmed: 9082363
Cancer Res. 2005 Jul 15;65(14):6111-9
pubmed: 16024612
Cancer. 1985 Nov 1;56(9):2155-60
pubmed: 3902203
Oncogene. 2005 Oct 6;24(44):6646-56
pubmed: 16007166
Int J Cancer. 2001 Feb 15;91(4):468-73
pubmed: 11251967
Int J Biol Markers. 2008 Jan-Mar;23(1):54-7
pubmed: 18409152
J Clin Oncol. 2009 Apr 1;27(10):1675-84
pubmed: 19255327
J Clin Endocrinol Metab. 2001 Aug;86(8):3779-86
pubmed: 11502811
J Clin Endocrinol Metab. 2005 Dec;90(12):6373-9
pubmed: 16174717
Ann Nucl Med. 1994 Nov;8(4):301-6
pubmed: 7535552
J Nucl Med. 2001 Jan;42(1):71-6
pubmed: 11197983
Eur J Nucl Med. 1999 Dec;26(12):1547-52
pubmed: 10638405
J Clin Endocrinol Metab. 2006 Aug;91(8):2892-9
pubmed: 16684830
J Clin Endocrinol Metab. 1999 Jul;84(7):2291-302
pubmed: 10404792
J Clin Endocrinol Metab. 2010 Nov;95(11):5018-27
pubmed: 20739388
Clin Oncol (R Coll Radiol). 2010 Aug;22(6):464-8
pubmed: 20452757
J Clin Endocrinol Metab. 2006 Jan;91(1):313-9
pubmed: 16263822
Eur J Endocrinol. 2012 Jan;166(1):5-11
pubmed: 21890651